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Abstract 10 
Aim: A patient’s journey with cancer can cause many different psychological disorders or 11 
exacerbate existing conditions. The field of psycho-oncology has found ways to link 12 
psychological disorders to cancer and research the effects of mental disorders on patient 13 
outcome and wellbeing.  14 
Method: This review looked at current literature in the field of psycho-oncology to 15 
understand how the stress level changes during the patient treatment journey. A systematic 16 
search was performed to identify relevant published articles on various electronic databases, 17 
including PubMed, ScienceDirect and Web of Science.  18 
Findings: The results show that there is a direct link between cancer diagnosis and increased 19 
stress, depression and anxiety within patients, not as medication side-effects and that these 20 
levels reduce over time mainly due to patient acceptance and either improved prognosis, or 21 
acceptance of death. Stress is complex and can precipitate many other psychological 22 
disorders. It has also been shown that early diagnosis of patients with mental disorders is 23 
crucial to improving long-term outcomes, as by accurately diagnosing and treating the mental 24 
illness will improve oncology patient overall health outcomes.  25 
 2 
Conclusion: There is need for adequate screening services for oncology patients and mental 26 
illness should become common practice.  27 
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 The data within this report showed that more cancers were 37 
registered in males than in females, with the average incidence in males being 667.4 per 38 
100,000 and the average incidence in females being 542.8 per 100,000. Of the cancers that 39 
were detected breast (15.4%), prostate (13.4%), lung (12.5%) and colorectal (11.6%) cancers 40 




Whilst much research is conducted in combatting cancer through introduction of new 43 
treatments, there are various ways in which cancer can affect patients. One such factor is the 44 
psychological stress a patient may encounter when learning of a cancer diagnosis. When 45 
patients are faced with such news a natural reaction is normally associated with negative 46 
thoughts, such as death and trauma, which in turn can lead to further mental health problems 47 
such as anxiety or depression. It is of great importance therefore that healthcare professionals 48 
screen for and understand how mental disorders can affect patients during their cancer 49 
journey. There is much evidence to suggest that improper care for patients with psychological 50 
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disorders associated with cancer can significantly impact patient’s quality of life, disability 51 
and if left untreated may worsen over time. 
[3], [4], [5], [6], [7], [8] Steroid use can affect patient’s 52 
psychological distress by leading to side effects such as insomnia, suicidal ideology and 53 
depressed mood. 
[9] [10]
 Research from Akechi found that between 3-35% of cancer patients 54 
experience full-syndrome post-traumatic stress disorder (PTSD) following diagnosis of 55 
terminal cancer. 
[11]
 This is understandable as the shock to the patient from realising they are 56 
in end stage cancer can trigger PTSD, which has been attributed to various factors such as 57 
age (i.e. those who are younger), sex (higher rates in females), physical symptoms (e.g. pain), 58 
the type of cancer (e.g. pancreatic cancer), the treatment therapy, hypercalcaemia, use of 59 
steroids, past history of major depression and social support.  60 
As stress can manifest in many forms, and preclude many different types of mental illness, it 61 
can be difficult to quantify.  62 
Methods and Design 63 
Aims 64 
The aim of this review was to explore the changes in stress levels and clinical presentation in 65 
cancer patients from all ages, documenting the changes from diagnosis to recovery, palliation 66 
or remission.  67 
Search Strategy 68 
A systematic search was performed to identify relevant published articles on various 69 
electronic databases, including Pubmed, ScienceDirect and Web of Science. The terms 70 
“Depression”, “Adjustment”, “Mood”, “Anxiety”, “PTSD”, “Stress”, “Cancer”, “Palliative“ 71 
and “Diagnosis” were used. The search was also conducted using standardised subject terms, 72 
Boolean operators and alternative spellings.  73 
Selection Criteria 74 
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Studies for the literature review were judged to be relevant if they met the following criteria: 75 
(i) all study participants had one or more definite cancer states diagnosed; (ii) all participants 76 
were adults, aged 18 or older; (iii) mental health issues due to the nature of cancer from 77 
diagnosis to palliation/recovery; (iv) depression or mental disorders associated with stress, 78 
caseness was determined by using diagnostic interviews (ICD-10 and/or DSM). Studies 79 
included for the review were from primary sources so as to obtain the full paper. Review 80 
papers were analysed mainly for background research and information regarding the issues 81 
concerning psycho-oncology. A few selection criteria were used to determine if the papers 82 
were to be used for the review. These included papers where results were reported for at least 83 
80% of the initial cohort size, papers with error or misdiagnosis of below 10% of the patient 84 
sample size, papers with clinically significant results (i.e. P value < 0.05) and papers who 85 
used similar inclusion and exclusion criteria for patient selection. It was envisaged that only 86 
papers with lager cohorts (i.e. above 100) would be used, however due to lack of available 87 
research this had to be relaxed and allow for any paper that met the preceding criteria to be a 88 
candidate for the review.  89 
Results 90 
After conducting the search strategy on various electronic databases, many of the articles 91 
found within the search strategy were excluded from the final review due to factors such as 92 
out-dated methodology (such as older versions of the DSM criteria not currently used in 93 
practice), non-clinically significant results and high rate of cohort dropout from the study. 94 
Out of the possible 131 there were 42 potential studies. After applying PICO principles 95 
(Patient/Population/Problem; Intervention; Comparison; Outcome) on the 42 articles, 15 96 
articles were chosen for this review as they met the quality criteria required for this study. 97 
Some of the remaining articles (out of the 42) were used in the introduction and discussion 98 
sections.  99 
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The final 15 articles that were selected were analysed and factors such as type of 100 
psychological disease researched, patient stage within cancer and overall cancer type within 101 
patients were compared. Significant results were highlighted and utilised for the results 102 
section of this thesis. Table 1 shows the fifteen articles used for the systematic review. The 103 
comparator for each paper was chosen by grouping all the articles together, listing all the 104 
similar variables and choosing a mental state that was compared against a standard, in this 105 
case cancer/type of cancer. The outcomes were chosen by reading the findings thoroughly 106 
and listing information which were relevant for this systematic review. In order to understand 107 
the significance of each specific outcome, the conclusions of each article were included in the 108 
last column.  109 
Insert table 1 here110 
Figure 1, shows the diagnostic prevalence of depression within the patients from each study. 111 
Each study has utilised a different method for diagnosis, for example Akechi used HADS and 112 
the mini-mental state examination (MMSE) examination, whereas Berard utilised BDI and 113 
HADS. 
[11] [12]
 The study from Berard was able to diagnose more patients with depression, 114 
especially when compared to results from Akechi. However, it also should be noted that the 115 
results from these two studies are not comparable in terms of patient number, the type of 116 
cancer in question and the inclusion and exclusion criteria. In general, studies that utilised 117 
SCID and the DSM criteria remained in the middle of the diagnostic horizon. 
[13] [14]
 118 
Insert figure 1 here  119 
When looking at the occurrence of PTSD within the study cohorts it is evident from Figure 2 120 
that the methodology used by Mehnert and Koch yielded the greatest number of diagnosed 121 
cases. 
[15]
 However, this result considers patients who had both PTSD stemming from their 122 
cancer diagnosis, and lifetime PTSD from other traumatic events. However, Kadan-Lottick 123 
 6 
and Matsuoka considered patients who had PTSD directly related to their cancer diagnosis 124 
separately from others producing more realistic results. 
[15] [17]
 125 
Insert figure 2 here 126 
Discussion 127 
Common Psychological Disorders within Cancer Patients 128 
Stress can alter the physiological status of a patient and can have both a positive and negative 129 
effect. Stress can be either acute or chronic, and it is chronic stress that can have long term 130 




Scales and Tests for Diagnosing Psychological Disorders 133 
When conducting the review, it was realised that there is no common scale for screening and 134 
diagnosing psychological disorders within cancer patients. Whilst there are scales that are 135 
routinely used, such as the Hospital Anxiety and Depression Scale (HADS), they are aimed at 136 
the general population, and do not consider cancers. 
[20]
 Therefore, whilst many studies 137 
employed the use of common scales, they were mainly adapted to suit oncology cohorts. 138 
Furthermore, many studies employed more than one type of scale for their sample cohorts. 139 
The commonly used scales were HADS, structured clinical interviews for the DSM 140 
framework (SCID), the Beck depression inventory (BDI), the schedule for affective disorders 141 
and schizophrenia (SADS), research diagnostic criteria (RDC), the brief symptoms inventory 142 
(BSI), the brief Edinburgh depression scale (BEDS), the Hamilton rating scale for depression 143 
(HAMD) and the schedule of attitudes towards hastened death (SAHD).
 [21-29]
  144 
The Hospital Anxiety and Depression Scale (HADS) 145 
This scale was originally developed by Zigmond and Snaith in 1983 and is routinely used by 146 
physicians to determine the levels of anxiety and depression that a patient is experiencing. It 147 
is a 14-item scale, has 14 questions, which generate ordinal data.
 [20]
 The scale is split evenly 148 
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between anxiety and depression and was designed to avoid the reliance of aspects that are 149 
common somatic symptoms of illness for the determination of anxiety or depression. These 150 
symptoms such as fatigue, hypersomnia and insomnia are avoided; thereby creating a scale 151 
that is useful for patients with physical health problems. Each item within the scale is scored 152 
from 0-3, meaning a patient can get a score between 0-21 for either anxiety or depression. 153 
The main aspect of this test is to determine an accurate cut-off for the scales to help diagnose 154 
correctly which mental illness the patient is suffering from. For example, research from 155 
Bjelland showed that a cut-off of 8/21 for anxiety or depression gives and specificity of 78% 156 
and a sensitivity (the number of non-cases correctly identified) of 90% for anxiety, and a 157 
specificity of 79% and a sensitivity of 83% for depression. 
[30]
 158 
A prominent case study that was researched was work from Akechi in 2004 who utilised 159 
HADS, in combination with a follow-up psychiatric interview, to determine the prevalence of 160 
major depression, adjustment disorders and PTSD within terminally ill cancer patients 161 
admitted to a palliative care unit (PCU) in Japan. It is estimated that between 3-35% of 162 
cancer patients experience full syndrome PTSD, which is understandable as the shock to the 163 
patients from realising they are terminally ill with cancer can trigger a severe emotional 164 
response.
 [31]
 Various factors that may attribute to this are including age (the younger), sex 165 
(females), physical symptoms (pain and nausea) and the therapy.
 [11]
 Akechi in 2004 took 166 
these factors into consideration, out of 209 patients, 85 completed both the HADS scale and 167 
the follow-up MMSE. As the patients were of Japanese origin, and English is not commonly 168 
spoken, the tests required translation into Japanese before they could be administered. The 169 
study used MMSE produced by Folstein in 1975, as well as the DSM criteria for PTSD in the 170 
terminally ill, where patients who had a score of 24 or more on the MMSE were re-171 
interviewed within 1 week of admission using HADS (34/209 patients had adjustment 172 
disorders and 14/209 had major depression). 
[32]
 At the follow-up, where the number of 173 
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patients had decreased to 85 (from 209), 4.7% had depressed mood, 3.5% had anxious mood 174 
and 2.4% had mixed emotions. After second admission, the number of patients had dropped 175 
again to 66 due to factors such as death and emergency admission to other care units. The 176 
follow-up interview showed 6/66 of patients had developed adjustment disorders, 4/66 had 177 
developed major depression, where 5/10 had no adjustment disorders on follow-up and 1 178 
patient transitioned from having adjustment disorders to having major depression. 
[11]
 179 
Although symptoms for PTSD were screened within the first 100 patients referred to the unit, 180 
the HADS scores revealed that none of these patients were suffering from PTSD, and 181 
therefore it was not carried on in the remaining 109 patients and it was also not screened in 182 
the follow-up interviews for the entire sample. 
[11]
 183 
A higher level of education within patients was deemed as a factor for stress, anxiety and 184 
depression as it was shown that these patients were able to fully realise the extent of a 185 
terminal diagnosis and how it would affect not only the rest of their lives, but also the lives of 186 
those around them, it was shown that religious beliefs had no effect. 
[11]
   187 
There was bias within the study as in the follow-up there were mainly female patients agreed 188 
to be interviewed. 
[11]
 This study found that the use of Fluoxetine in patients was beneficial at 189 
reducing symptoms of both adjustment disorders and major depression and could be added to 190 
a patient’s regime. This study did reveal however that the HADS scale is an excellent 191 
preliminary test that can accurately diagnose anxiety and depression within patients. 
[11]
 192 
The DSM and SCID Frameworks 193 
Whilst the DSM has been used as a standard for many years, it has undergone criticism for 194 
being an unscientific and subjective system.
 [33]
 It has also been scrutinised for relying on the 195 
use of superficial symptoms, having unclear division from what is considered to be normality 196 
and having cultural bias.
 [34]
 However, when combined with SCID it has been given validity 197 
in accurately diagnosing a wide variety of mental illnesses. 
[22]
 The SCID process can take 198 
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between 1-2 hours depending on the complexity of the patients’ psychiatric history and their 199 
ability to clearly describe their past experiences. The interview is designed such that either a 200 
psychologist or psychiatrist administers it, however with adequate training many researchers 201 
can also utilise this tool.  202 
In another study by Akechi in 2010 included one of the largest cohorts from records of 203 
psychiatric division of a local hospital. Of the 5431 patients who were referred, 329 males 204 
and 399 females were diagnosed with major depression. 
[35]
 The study also looked at suicidal 205 
ideation within these patients and found that among those that had major depression, 136 206 
males and 157 females also had suicidal thoughts. 
[35]
 The results also show that of the 207 
patients referred to the unit, 40% has suicidal thoughts, and this did not change greatly with 208 
gender. 
[35]
 However, it was noticed that a more advanced cancer in males would lead to 209 
suicidal ideation, and that females with suicidal ideation are more likely to seek help with 210 
their feelings than males are. 
[35]
 211 
A larger, multi-site study from Lichtenthall in 2009 looked at the prevalence of mental 212 
disorders in palliative patients with advanced cancer. 
[36]
 The main criteria for the study were 213 
that the patients were diagnosed with advanced cancer, were 20 years or older, had adequate 214 
health to complete the questionnaires, were diagnosed at the site this research was conducted 215 
and had some level of informal caregiving. 
[36]
 This study used modified inventory of 216 
complicated grief to diagnose prolonged grief disorder (PGD) in those coping with cancer 217 
and the SCID. Interestingly Lichtenthall results showed that the prevalence of depression and 218 
anxiety does not increase as death nears, as it was concluded by Akechi in 2010 which 219 
thought to be due to acceptance. The results were compared to Kadan-Lottick in 2005 study 220 
of 251 patients with advanced cancer where 12% of patients met the criteria for major 221 
psychiatric conditions.
 [16]
 This study used patient utilisation of mental health services, as an 222 
indicator of their willingness to deal with the issues despite having terminal cancer. 
[16]
 It was 223 
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found that 28% of patients had accessed a mental health intervention for their psychiatric 224 
conditions, and that 90% of patients were willing to be treated. A study by Ciaramella and 225 
Poli looked at using SCID in conjunction with the Hamilton depression rating scale (HAMD) 226 
to diagnose depression and anxiety in 100 consecutive patients admitted to a palliative care 227 
unit. 
[13]
 The patients had an even split between males and females, of which 79/100 were on 228 
chemotherapy, 37/100 were taking analgesic drugs, 12/100 were on corticosteroids and 229 
28/100 were on multiple treatments. 
[13]
 Initial contact with patients involved a structures 230 
interview and this was followed up with an assessment with a psychiatrist, pain was assessed 231 
using the McGill pain questionnaire, SCID, the Endicott criteria and HAMD were then used.
 232 
[37]
 It was found that 49% of patients had current depression using SCID, 29% were identified 233 
using the Endicott criteria and 28% were found using both scales as having major depression 234 
associated with cancer. Lifetime depressive disorders were identified in 9 patients and the 235 
pain results showed that 37% of patients were experiencing pain with their conditions.
 [13]
 In 236 
Ciaramella and Poli study, depression increased in male patients, which is contrary to other 237 
studies by Gurevich and Akechi (2004) 238 
 where females were more likely to develop major depression, 50% of patients with 239 
metastasis were clinically depressed.  240 
One study by Mehnert and Koch in 2007 looked at identifying psychiatric conditions such as 241 
PTSD and other mental disorders within 127 breast cancer patients. This study utilised SCID 242 
and reviewed patients’ post-surgery and after 6 months to gauge the long-term effects of 243 
mental illness. The interviews focussed on lifetime PTSD, cancer related PTSD, anxiety 244 
disorders, major depression and cancer related anxiety. 
[15]
 It was found that most patients 245 
(87%) found the cancer diagnosis as unexpected and overwhelming and that 23% of patients 246 
believed that the diagnosis and surgery were not the most distressing aspects of the disease, 247 
and were fearful of the future prognosis. This however improved with time and it was found 248 
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A shortened version of SCID was utilised by Burgess in 2005, who looked at a 5-year 251 
observational assessment of females with breast cancer post diagnosis. Of the 222 eligible 252 





 The primary analysis showed that the baseline level of depression in 254 
patients was 33% of the sample cohort, however, this decreased after the first follow-up at 3 255 
months to 24%. At a 5-month interview the study looked at the effects of social stress, and it 256 
was found that up to 4 months’ post diagnosis the levels of stress decreased in patients. [15] 257 
The consensus of this study also concluded that depression decreased with time and this was 258 
attributed to acceptance by patients, as well as increased level of coping with their diagnosis. 259 
[15]
 It was also found that after remission the levels of stress, depression and anxiety in 260 
women who had breast cancer decrease to the levels of that within the general female 261 
population. 
[15]
 However, it was also noted that on-going treatment is essential, and adequate 262 
psychological support may decrease the prevalence of chronic depression and anxiety in 263 
women who lack a confiding relationship within their personal lives. 
[15]
  264 
The Beck Depression Inventory (BDI) 265 
Beck and Worthen’s 1972 Beck Depression Inventory (BDI) factors in various symptoms of 266 
depression such as irritability, hopelessness, cognitions such as guilt or negative thoughts and 267 
physical symptoms such as fatigue, weight loss and anhedonia. 
[38]
 Whilst the inventory is 268 
excellent self-completed questionnaire to diagnose depression, accordingly, the results can be 269 
easily affected by the person completing the scale. 
[38]
 270 
A study by Berard in 1998 combined the BDI with a structured interview to determine the 271 
depressive disorders found in patients with breast cancer, head and neck cancer and 272 
lymphoma. 
[12]
 The main factor within BDI that was stressed was patient self-loathing and 273 
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negative attitudes. The BDI scale was then also conjoined with the HADS scale, which 274 
focussed on the physically ill who had anhedonia. The cohort who undertook BDI amounted 275 
to 245 patients, of which 100 went on to have structured interviews.
 [12]
 Patient recruitment 276 
occurred within the waiting area of a clinic in South Africa where many patients had to wait 277 
for up to two hours to be seen by a clinician. This was seen to be a factor that influences their 278 
negative responses. 
[12]
 However, 70% of patients had high score, 24% of patients’ low score 279 
and only 6% obtained a score of zero for both HADS and BDI. It was noted that although 280 
effort was taken to obtain more males for the study, 75% of the patients who agreed to the 281 
interview were female, which could increase the results seen.
 [12]
 There were 54% of patients 282 
in remission. Although the study results were favourable when compared with other studies, 283 
this study used a lover cut-off score for HADS (8 or under), which meant that more patients 284 
would be classified as depressed. It was noted that misclassification occurred within less than 285 
10% of patients, indicating that the lover cut-off is generally successful. A total of 18% of 286 
patient tested positive on both the HADS and BDI scales, and the results from this study led 287 
way to the BDI scale being proposed as a tool for diagnosing patients in hospital and clinic 288 
waiting areas.
 [12]
 Berard’s study did exclude patients who were unable to function due to 289 
their disease state, and this would have altered the levels of stress and depression seen. 290 
Furthermore, the samples of patients not interviewed or tested may have shown more cases of 291 
depressive disorders as reported by their clinicians.
 [12]
 As this was only an outpatient 292 
department, there may have been more cases within the inpatients. The study did show 293 
however that cancer might not be the sole reason for depression within patients, as other 294 
elements such as finances, relationships and social support are all contributing factors. 
[12]
  295 
The Schedule for Affective Disorders and Schizophrenia (SADS) 296 
The schedule for affective disorders and schizophrenia is a collection of psychiatric 297 
diagnostic criteria and symptom-rating scales originally founded by Endicott and Spitzer in 298 
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1978, and is organised as a semi-structured interview rather than a questionnaire.
 [24]
 The 299 
interviews look for specific sets of symptoms and screen based on patient positivity towards 300 
these symptoms, by looking at the same set of disorders regardless of the patients presenting 301 
problem.
 [24]
 Unlike full structures interviews, SADS is flexible as it allows the interviewer to 302 
rephrase the questions based upon patient understanding and scores are based on clinical 303 
judgement. It also can be used with research diagnostic criteria (RDC) to allow for more 304 
accurate diagnosis. 
[25]
 Much as the name suggests the interview screens for schizophrenia, 305 
but also screens for major depression, anxiety and bipolar disorder. In recent years, however 306 
it has been replaced largely by fully structured interviews, but a research paper by Chochinov 307 
et al in 2004 used the SADS and RDC structure to help diagnose patients. 
[39]
 The study was 308 
initialised by a simple yes/no answer to the question ‘are you depressed?’ This simplicity 309 
allowed patients to be quickly screened for the SADS interview, 197 patients were enrolled. 310 
Within this cohort 94 patients were males, and the rest were females. The SADS interview 311 
process was completed both without and with the RDC criteria to accurately determine the 312 
effectives of the SADS interview. The BDI and a visual analogue test were also administered 313 
to controls.
 [39]
 Results showed that a total of 24 patients were found to have some form of 314 
depression. It was noted that the SADS interview, without the RDC criteria, misdiagnosed 4 315 
patients as not depressed. The analogue test was the worst at diagnosis by misclassifying 7 316 
patients as not depressed and 87 patients that were not depressed as depressed.
 [39]
 It was 317 
found that results were similar to another study (Lloyd-Williams et al, 2003) that found that 318 
SADS is capable of accurately diagnosing patients following a simple initial question of if 319 
they were depressed.
 [39]
 These studies show that SADS is capable of being a great screening 320 
tool, and by combining it with the RDC criteria and BDI it can screen and diagnose patients 321 
quickly and effectively.  322 
The Brief Edinburgh Depression Scale (BEDS) 323 
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The brief Edinburgh depression scale (BEDS) by Lloyds-Williams et al in 2007 is a 6-item 324 
questionnaire that is based off the commonly used Edinburgh depression scale (EDS), 325 
however it excludes the somatic symptoms of depression, and focuses mainly on feeling of 326 
worthlessness, sadness and suicidal ideation.
 [40]
 The brief scale in this study was used for 327 
brevity and was tested on patients in a palliative care centre with 6 months or fewer 328 
prognoses of their terminal cancers.
 [40]
 The only exclusion criteria for this study were 329 
patients with cerebral metastases or those with a prognosis of one week or less. Patients who 330 
completed the BEDS questionnaire were then interviewed using MMSE to confirm diagnosis. 331 
Initially 246 patients were identified, however after loss due to patient’s declination and 332 
exclusion due to cognitive impairment, only 180 patients remained (139 female and 41 male).
 333 
[40]
 It was found that a valid cut off for the BEDS scale would be scores of 6 or more, and 334 
through utilisation of the scale it was found that 34 % of patients were diagnosed with 335 
depression. This was analysed against the full 10 item EDS, and it was found that results are 336 
similar.
 [40]
 The BEDS questionnaire was shown to have great selectivity and specificity 337 
within the sample patients, however does require further research to validate findings in other 338 
cohorts.
 [40]
  339 
Conclusion 340 
The incorporation of a psychiatric screening method for cancer patients has yielded increased 341 
diagnosis of mental health issues, and therefore it should be recommended as part of the 342 
holistic approach to patient care.
 [11], [15], [27]
 It is well understood that the diagnosis and 343 
treatment of cancer can be a stressful endeavour, and is it natural to assume that a patient will 344 
experience some level of stress throughout their journey. Many of the studies in this review 345 
focussed mainly on depression, as it is common within patients with cancer.
 [11]
  346 
When analysing results from various studies, it was found that HADS is effective in 347 
diagnosing depression accurately in cancer patients.
 [12]
 Studies that have utilised the DSM 348 
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criteria have also found great success in accurately diagnosing depression in cancer patients 349 
(Desai et al., 1999; Ciaramella and Poli, 2001; Burgess et al., 2005; Breitbart et al., 2012).
 350 
[7],[13],[14],[29]
 It is crucial that the correct cut-off criteria and scores are used in order to avoid 351 
having bias within results and allow comparison of results. The average cut-off for SCID is 352 
around 12 and this was used by most studies. 
[35]
 When looking at more complex issues such 353 
as PTSD it can be hard to differentiate from a previous un-diagnosed issue.
 [15]
 It was found 354 
that there are very few scales that help to diagnose PTSD within cancer patients.
 [17]
 Research 355 
from Matsuoka et al in 2002 however found that there were few patients who had PTSD from 356 
their cancer diagnosis, and many people who did have confirmed PTSD which was un-357 
diagnosed after traumas occurred many years ago.
 [15]
 358 
As the patient progresses throughout their cancer journey they may also go through the stages 359 
of grief outlined by Kubler-Ross in 1969, where acceptance of their fate and cancer diagnosis 360 
can also mean that levels of depression may improve with the progression of treatment or the 361 
disease.
 [11], [13], [14]
 As there are many different types of cancer, each patient journey is 362 
different, and therefore mental health can differ from patient to patient. The variation 363 
between genders has also been realised, whereby females were more likely to develop a 364 
depressed mood and exhibit greater levels of stress, anxiety and depression than within the 365 
male population.
 [13]
 Patients who were in palliative care also displayed similar levels of 366 
depression, anxiety and adjustment disorders than with those with new diagnosis, however, it 367 
was found in studies that patients soon come to terms with their terminal status and 368 




 There is a need 369 
for adequate screening services specific to oncology patients.  370 
Study limitations 371 
There were few papers found regarding stress and cancer. The papers analysed were on 372 
psychiatric disorders that can stem from stress, such as depression, anxiety and PTSD.  373 
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Practical implication: this review reveals that while stress and mental health issues are 374 
common in patients diagnosed with cancer. Future studies will be required to modify the 375 
tools proved to be effective to suite cancer patients. By improving cancer patients’ mental 376 
state, adherence to treatment including pharmacological therapy may improve leading to 377 
better health outcomes.  378 
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